ACA · trading date Oct 13, 2026 · previous close $147.36 · source: Alpaca (IEX feed, not consolidated full-market data).
Key Financials
Revenue
$2.88B
Net income
$208.40M
Total assets
$4.99B
Total liabilities
$2.34B
Stockholders' equity
$2.64B
Cash & equivalents
$214.60M
Operating income
$341.90M
Operating cash flow
$341.10M
Capital expenditures
$165.60M
Fiscal year 2025, via 10-K filed 2026-02-27.
A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
11.9%
Net margin
7.2%
Free cash flow
$175.50M
Free cash flow margin
6.1%
Liabilities / assets
47.0%
Equity / assets
53.0%
CapEx / revenue
5.7%
Operating cash flow / net income
1.64×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Dallas, TX 75201
500 N. AKARD SREET
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:58 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.